Difference between revisions of "Team:iTesla-SoundBio/design"

 
(82 intermediate revisions by 6 users not shown)
Line 1: Line 1:
 +
{{iTesla-SoundBio}}
 +
<html>
  
−
<meta charset="utf-8">
 
−
<meta name="viewport" content="width=device-width, initial-scale=1">
 
−
<style>
 
−
* {
 
−
    box-sizing: border-box;
 
−
}
 
  
 +
<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
 +
<script>
 +
$(document).ready(function(){
 +
  // Add smooth scrolling to all links
 +
  $("a").on('click', function(event) {
 +
 +
    // Make sure this.hash has a value before overriding default behavior
 +
    if (this.hash !== "") {
 +
      // Prevent default anchor click behavior
 +
      event.preventDefault();
 +
 +
      // Store hash
 +
      var hash = this.hash;
 +
 +
      // Using jQuery's animate() method to add smooth page scroll
 +
      // The optional number (800) specifies the number of milliseconds it takes to scroll to the specified area
 +
      $('html, body').animate({
 +
        scrollTop: $(hash).offset().top
 +
      }, 800, function(){
 +
 +
        // Add hash (#) to URL when done scrolling (default click behavior)
 +
        window.location.hash = hash;
 +
      });
 +
    } // End if
 +
  });
 +
});
 +
</script>
 +
 +
<style>
 
body {
 
body {
−
     font-family: Arial, Helvetica, sans-serif;
+
     font-family: "Lato", sans-serif;
−
    height: 100h;
+
−
    width: 100w;
+
 
}
 
}
  
−
/* Style the header */
+
.sidenav {
−
.header {
+
    height: 80%;
−
     background-color: #f1f1f1;
+
    width: 180px;
−
     padding: 30px;
+
    position: fixed;
−
     text-align: center;
+
    z-index: 1;
−
     font-size: 35px;
+
    top: 0;
 +
    left: 0;
 +
     background-color: #111;
 +
     overflow-x: hidden;
 +
     padding-top: 130px;
 +
     padding-bottom: 130px
 
}
 
}
  
−
 
+
.sidenav a {
 +
    padding: 5px 5px 5px 5px;
 +
    text-decoration: none;
 +
    font-size: 20px;
 +
    color: #818181;
 +
    display: block;
 
}
 
}
  
−
/* Clear floats after the columns */
+
.sidenav a:hover {
−
.row:after {
+
     color: #f1f1f1;
−
     content: "";
+
−
    display: table;
+
−
    clear: both;
+
 
}
 
}
  
−
/* Style the footer */
+
.main {
−
.footer {
+
     margin-left: 180px; /* Same as the width of the sidenav */
−
     background-color: #f1f1f1;
+
     padding: 0px 10px;
−
     padding: 10px;
+
     font-family: arial;  
−
     text-align: center;
+
    font-size: 20px;
 +
    padding: 30px
 
}
 
}
−
/* Make the text over image*/
+
@media screen and (max-height: 450px) {
−
.container {
+
     .sidenav {padding-top: 15px;}
−
     position: relative;
+
     .sidenav a {font-size: 18px;}
−
     text-align: center;
+
−
    color: black
+
 
}
 
}
−
.container1 {
+
.graphicsum {
−
    position: relative;
+
  width: 100%;
−
    text-align: center;
+
  margin: auto;
−
    color: white
+
 
}
 
}
 +
.text {
 +
    font-size: 20px;
 +
    letter-spacing: .16em;
 +
    padding-left: 10px;
 +
    padding-right: 100px;
 +
    padding-top: 10px;
 +
    padding-bottomL 10px;
 +
    color: white;
 +
 
 +
}
 +
.horizontalline {
 +
    border: 2px solid black;
 +
    width: 100%;
 +
    height: 1 px;
 +
    margin: auto;
 +
    margin-top: 50px;
 +
    margin-bottom: 50px;
 +
}
 +
h1 {
 +
    font: 600 1.5em/1 'Raleway', sans-serif;
 +
    color: rgba(0,0,0,.5);
 +
    text-align: center;
 +
    text-transform: uppercase;
 +
    letter-spacing: .5em;
 +
    top: 25%;
 +
    width: 100%;
 +
padding-top: 50px;
 +
        padding-bottom: 50px;
  
−
.centered {
+
}
−
     position: absolute;
+
span, span:after {
−
     bottom: 8px;
+
     font-weight: 900;
−
     left: 50%;
+
     color: #efedce;
−
     transform: translate(-50%, -50%);
+
     white-space: nowrap;
 +
     display: inline-block;
 +
    letter-spacing: .1em;
 +
    padding: .2em 0 .25em 0;
 
}
 
}
  
−
/* Style the top navigation bar */
+
span {
−
.topnav {
+
     font-size: 4em;
−
     overflow: hidden;
+
     z-index: 100;
−
     background-color: #333;
+
    text-shadow: .04em .04em 0 #9cb8b3;
 
}
 
}
  
−
/* Style the topnav links */
+
span:after {
−
.topnav a {
+
    content: attr(data-shadow-text);
−
     float: left;
+
    color: rgba(0,0,0,.35);
−
     display: block;
+
    text-shadow: none;
−
     color: #f2f2f2;
+
    position: absolute;
−
     text-align: center;
+
    left: .0875em;
−
     padding: 14px 16px;
+
    top: .0875em;
−
     text-decoration: none;
+
    z-index: -1;
 +
    -webkit-mask-image: url(https://f.cl.ly/items/1t1C0W3y040g1J172r3h/mask.png);
 +
}
 +
.horizontalline {
 +
     border: 2px solid black;
 +
     width: 50%;
 +
     height: 1 px;
 +
     margin: auto;
 +
     margin-top: 50px;
 +
     margin-bottom: 10px;
 
}
 
}
  
−
/* Change color on hover */
+
ol{
−
.topnav a:hover {
+
margin-left: 220px;
−
    background-color: #ddd;
+
font-size: 20px;
−
    color: black;
+
 
}
 
}
  
−
 
+
p{
 +
margin-left: 220px;
 +
font-size: 20px;
 
}
 
}
 +
 
</style>
 
</style>
−
</head>
+
 
 
<body>
 
<body>
−
<div class="topnav">
+
<center>
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio">Home Page</a>
+
<script>
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/team">Team</a>
+
    $("#title").text("Design")
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/description">Description</a>
+
 
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/design">Design</a>
+
</script>
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/Experiment">Experiment</a>
+
</center>
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/Project/Interlab">InterLab</a>
+
 
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/Project/results">Results</a>
+
 
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/Project/Parts">Parts</a>
+
 
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/Project/Safety">Safety</a>
+
<div class="sidenav">
−
  <a href="https://2018.igem.org/Team:iTesla-SoundBio/OldMainPage.html">Old Main Page</a>
+
<a href="#Phase1"><img src="https://static.igem.org/mediawiki/2018/d/d8/T--itesla-soundbio--phase1.png" alt="Phase 1" style="width:100%"></a>
 +
<br>
 +
<a href="#Phase2"><img src="https://static.igem.org/mediawiki/2018/2/21/T--itesla-soundbio--phase2.png" alt="Phase 2" style="width:100%"></a>
 +
<br>
 
</div>
 
</div>
 +
 +
<center><h2 style="margin-left: 200px;" id="lesserTitle">Introduction</h2></center>
 +
<center><p style="font-size: 25px; margin-left: 200px; margin-right: 40px;">The goal of our project was to recreate the first protein involved in the LAL cascade (Factor C) by using Bacillus subtilis, a gram-positive bacteria, to synthesize the protein of interest. Additionally, we wanted to find an alternative method to detect cleaved factor C. When detecting cleaved Factor C, our goal was to cut down on intermediate steps in the LAL cascade (factor B, clotting enzyme) and skip directly to an engineered reaction that is easily detectable, such as a visual assay. To briefly summarize our project design, it can be explained in two phases.</p></center>
 +
 +
<div id="Phase1">
 +
<h2 style="margin-left: 200px;" id="lesserTitle">Phase 1</h2>
 +
<p><b>Overview:</b> Produce and purify Factor C from <em>Bacillus subtilis</em></p>
 +
<ol>
 +
<li>Acquire the amino acid sequence from factor C and translate it into codons. Codon optimizes it for <em>Bacillus subtilis</em></li>
 +
<ul style="font-size: 20px;">
 +
<li >After acquiring the full sequence for the Factor C gene, split into two fragments to meet IDT&rsquo;s limits on sequence length. The end of the first fragment and the end of the second fragment had a shared cut site of the BglII restriction enzyme.</li>
 +
</ul>
 +
</li>
 +
<li>Digest Fragment I and psb1C3 with EcoRI and PstI</li>
 +
<li>Ligate Fragment I and psb1C3</li>
 +
<li>Digest the Fragment I and psb1C3 construct with BglII and PstI</li>
 +
<li >Digest Fragment II with BglII and PstI </li>
 +
<li >Ligate Fragment II into the Fragment I and psb1C3 construct</li>
 +
<li >Transform into E. coli</li>
 +
<p>---------------- At this point we have a plasmid with the entire factor C gene in E. coli-----------------</p>
 +
<li>Miniprep E. coli for the Factor C gene</li>
 +
<li >Digest with BamHI and SacI to isolate factor C</li>
 +
<ul style="font-size: 20px;">
 +
<li >Gel extraction and purification of the factor C band &nbsp;</li>
 +
</ul>
 +
<li >Digest pAX01 with BamHI and SacII</li>
 +
<li>Ligate pAX01 and Factor C</li>
 +
<li>Transform into <em>B. subtilis 168</em></li>
 +
<li>His-tagged Protein Purification of factor C</li>
 +
 +
</ol>
 +
 +
 +
<p>
 +
<b>Verification: </b>
 +
western blot with Bacillus subtilis that has the pax0I Factor C insert. One will have Bacillus that has been induced by xylose and the other will not be induced.
 +
</p>
 +
<p><br /><br /></p>
 +
 +
<img style="width: 65%; margin-left: 330px" src="https://static.igem.org/mediawiki/2018/e/e5/T--iTesla-SoundBio--DesignP1.png">
 +
</br></br>
 +
</div>
 +
 +
<div id="Phase2">
 +
<h2 style="margin-left: 200px;" id="lesserTitle">Phase 2</id></h2>
 +
<p>
 +
<b>Objective:</b>
 +
Find an alternative procedure using the Factor C we produced to replace the LAL assay that is as effective, cheaper, and does not need horseshoe crab blood compared to industry options for endotoxin tests.
 +
</p>
 +
 +
<p>
 +
<b>Option I:</b>
 +
We could synthesize all the relevant proteins for the natural coagulation cascade
 +
</p>
 +
<ul style="font-size: 20px; margin-left: 200px">
 +
 +
<li>Here is how it could look in terms of design:</li>
 +
<ul>
 +
<li>Since it is not Factor C we do not have to transfer it to Bacillus subtilis</li>
 +
<li>1) Get the DNA sequence and add a His-tag for Factor B,</li>
 +
<li>2) DIgest with enzymes so that we can ligate it into psb1C3</li>
 +
<li>3) Transform into E. coli</li>
 +
<li>4) His-tagged Protein Purification of factor C</li>
 +
<li>5) repeat with clotting enzyme, and substrate</li>
 +
<li>6) Once all the other compounds have been isolated, we can mix them with factor C</li>
 +
<ul>
 +
<li>Pros: Should work, in theory</li>
 +
<li>Cons: Almost certainly difficult/expensive</li>
 +
</ul>
 +
</ul>
 +
</ul>
 +
</p>
 +
</div>
 +
 +
<div class="horizontalline" style="margin-left: 480px">
 +
</div>
 +
</body>
 +
 +
 +
 +
</html>
 +
 +
<!--
 +
#boxshadow {
 +
    position: relative;
 +
    box-shadow: 1px 2px 4px rgba(0, 0, 0, .5);
 +
    padding: 10px;
 +
    background: white;
 +
}
 +
 +
#boxshadow img {
 +
    width: 100%;
 +
    border: 1px solid #8a4419;
 +
    border-style: inset;
 +
}
 +
 +
#boxshadow::after {
 +
    content: '';
 +
    position: absolute;
 +
    z-index: -1; /* hide shadow behind image */
 +
    box-shadow: 0 15px 20px rgba(0, 0, 0, 0.3);
 +
    width: 70%;
 +
    left: 15%; /* one half of the remaining 30% */
 +
    height: 100px;
 +
    bottom: 0;
 +
}
 +
background-color: #008CBA;
 +
    border: none;
 +
    color: white;
 +
    padding: 15px 32px;
 +
    text-align: center;
 +
    text-decoration: none;
 +
    display: inline-block;
 +
    font-size: 16px;
 +
    margin: 4px 2px;
 +
    cursor: pointer;
 +
  display: flex; justify-content: center;
 +
}
 +
-->

Latest revision as of 14:15, 16 October 2018

Safety Protocols
InterLab
Team Members Attributions
Human Practices Collaborations
Project Description Design Results Biobrick Parts Lab Notebook
iT-SB 2018 iT-SB 2017

Phase 1
Phase 2

Introduction

The goal of our project was to recreate the first protein involved in the LAL cascade (Factor C) by using Bacillus subtilis, a gram-positive bacteria, to synthesize the protein of interest. Additionally, we wanted to find an alternative method to detect cleaved factor C. When detecting cleaved Factor C, our goal was to cut down on intermediate steps in the LAL cascade (factor B, clotting enzyme) and skip directly to an engineered reaction that is easily detectable, such as a visual assay. To briefly summarize our project design, it can be explained in two phases.

Phase 1

Overview: Produce and purify Factor C from Bacillus subtilis

  1. Acquire the amino acid sequence from factor C and translate it into codons. Codon optimizes it for Bacillus subtilis
    • After acquiring the full sequence for the Factor C gene, split into two fragments to meet IDT’s limits on sequence length. The end of the first fragment and the end of the second fragment had a shared cut site of the BglII restriction enzyme.
  2. Digest Fragment I and psb1C3 with EcoRI and PstI
  3. Ligate Fragment I and psb1C3
  4. Digest the Fragment I and psb1C3 construct with BglII and PstI
  5. Digest Fragment II with BglII and PstI
  6. Ligate Fragment II into the Fragment I and psb1C3 construct
  7. Transform into E. coli

    8. ---------------- At this point we have a plasmid with the entire factor C gene in E. coli-----------------

  8. Miniprep E. coli for the Factor C gene
  9. Digest with BamHI and SacI to isolate factor C
    • Gel extraction and purification of the factor C band  
  10. Digest pAX01 with BamHI and SacII
  11. Ligate pAX01 and Factor C
  12. Transform into B. subtilis 168
  13. His-tagged Protein Purification of factor C

Verification: western blot with Bacillus subtilis that has the pax0I Factor C insert. One will have Bacillus that has been induced by xylose and the other will not be induced.





Phase 2

Objective: Find an alternative procedure using the Factor C we produced to replace the LAL assay that is as effective, cheaper, and does not need horseshoe crab blood compared to industry options for endotoxin tests.

Option I: We could synthesize all the relevant proteins for the natural coagulation cascade

  • Here is how it could look in terms of design:
    • Since it is not Factor C we do not have to transfer it to Bacillus subtilis
    • 1) Get the DNA sequence and add a His-tag for Factor B,
    • 2) DIgest with enzymes so that we can ligate it into psb1C3
    • 3) Transform into E. coli
    • 4) His-tagged Protein Purification of factor C
    • 5) repeat with clotting enzyme, and substrate
    • 6) Once all the other compounds have been isolated, we can mix them with factor C
      • Pros: Should work, in theory
      • Cons: Almost certainly difficult/expensive